Zymeworks Company

Zymeworks is a global biotechnology company focused on developing novel, multifunctional therapeutics for difficult-to-treat cancers and other serious diseases. Their fully integrated R&D engine, powered by a team of world-class researchers, allows them to discover, develop, and commercialize their novel agents globally with partners and collaborators. Zymeworks thrives on scientific challenges and strives to deliver transformational therapies for patients. Their growing pipeline of novel therapeutics is supported by best-in-class antibody-drug conjugates and multispecific antibody therapeutics technology platforms. By bringing people together in purpose, Zymeworks aims to solve the world's most challenging medical problems.


Investors

Founded Date: 2004
Headquarters: Vancouver, British Columbia, Canada
Industry: End-to-End Drug Development